196 related articles for article (PubMed ID: 17627563)
1. Angiogenic growth factors in the treatment of peripheral arterial disease.
Mikroulis D; Papanas N; Maltezos E; Bougioukas G
Curr Vasc Pharmacol; 2007 Jul; 5(3):195-209. PubMed ID: 17627563
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial.
Mohler ER; Rajagopalan S; Olin JW; Trachtenberg JD; Rasmussen H; Pak R; Crystal RG
Vasc Med; 2003; 8(1):9-13. PubMed ID: 12866606
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic angiogenesis for ischemic diseases].
Aoki M; Morishita R
Nihon Rinsho; 2006 Apr; 64(4):762-8. PubMed ID: 16613196
[TBL] [Abstract][Full Text] [Related]
5. Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene.
Morishita R; Sakaki M; Yamamoto K; Iguchi S; Aoki M; Yamasaki K; Matsumoto K; Nakamura T; Lawn R; Ogihara T; Kaneda Y
Circulation; 2002 Mar; 105(12):1491-6. PubMed ID: 11914260
[TBL] [Abstract][Full Text] [Related]
6. Gene-based therapeutic angiogenesis.
Yeh JL; Giordano FJ
Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):236-49. PubMed ID: 12973701
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic angiogenesis for peripheral artery disease: gene therapy.
Nikol S
Vasa; 2007 Aug; 36(3):165-73. PubMed ID: 18019272
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction.
Makarevich PI; Dergilev KV; Tsokolaeva ZI; Boldyreva MA; Shevchenko EK; Gluhanyuk EV; Gallinger JO; Menshikov MY; Parfyonova YV
PLoS One; 2018; 13(5):e0197566. PubMed ID: 29787588
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects.
Guo M; Shi JH; Wang PL; Shi DZ
J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):130-141. PubMed ID: 29025278
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
11. Cell therapy in peripheral arterial disease.
Al Mheid I; Quyyumi AA
Angiology; 2008 Dec-2009 Jan; 59(6):705-16. PubMed ID: 18818233
[TBL] [Abstract][Full Text] [Related]
12. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.
Losordo DW; Dimmeler S
Circulation; 2004 Jun; 109(21):2487-91. PubMed ID: 15173038
[No Abstract] [Full Text] [Related]
14. Multi-scale computational models of pro-angiogenic treatments in peripheral arterial disease.
Mac Gabhann F; Ji JW; Popel AS
Ann Biomed Eng; 2007 Jun; 35(6):982-94. PubMed ID: 17436110
[TBL] [Abstract][Full Text] [Related]
15. Coadministration of adipose-derived stem cells and control-released basic fibroblast growth factor facilitates angiogenesis in a murine ischemic hind limb model.
Horikoshi-Ishihara H; Tobita M; Tajima S; Tanaka R; Oshita T; Tabata Y; Mizuno H
J Vasc Surg; 2016 Dec; 64(6):1825-1834.e1. PubMed ID: 26597457
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic angiogenesis for critical limb ischemia.
Ko SH; Bandyk DF
Semin Vasc Surg; 2014 Mar; 27(1):23-31. PubMed ID: 25812756
[TBL] [Abstract][Full Text] [Related]
17. Medical therapy for intermittent claudication.
Rowlands TE; Donnelly R
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):314-21. PubMed ID: 17532651
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor 1 in lower limb ischemia.
Ho TK; Abraham DJ; Black CM; Baker DM
Vascular; 2006; 14(6):321-7. PubMed ID: 17150152
[TBL] [Abstract][Full Text] [Related]
19. Gene and stem cell therapy in peripheral arterial occlusive disease.
Kalka C; Baumgartner I
Vasc Med; 2008; 13(2):157-72. PubMed ID: 18593804
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis--a new goal in peripheral artery occlusive disease therapy.
Mäkinen K
Acta Chir Belg; 2003 Oct; 103(5):470-4. PubMed ID: 14653030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
